DCF Advisers »

Revance Therapeutics shares owned by DCF Advisers

Quarter-by-quarter ownership of Revance Therapeutics shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by DCF Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $387k 600k 0.64
2024-03-31 $426k 600k 0.71